Literature DB >> 11181801

Hepatocyte growth factor receptor in acute tubular necrosis.

Ralph Rabkin1,2, Fernando Fervenza1,2, Tanny Tsao1,2, Richard Sibley3, Michael Friedlaender1,2, Fay Hsu1,2, Charles Lassman3, Michael Hausmann1,2, Phil Huie3, Ralph H Schwall4.   

Abstract

In acute tubular necrosis, there are early transient increases in circulating and local bioactive hepatocyte growth factor (HGF) levels and renal HGF receptor (c-MET) gene expression. It has therefore been suggested that endogenous HGF may play a role in initiating renal repair. To test this hypothesis, changes in the levels, activity, and anatomic distribution of c-MET protein were characterized in relation to the onset and localization of DNA synthesis in kidneys of rats with ischemia-induced acute tubular necrosis. Whole-kidney c-MET protein levels were significantly increased in the injured kidneys 12 h after injury and rose to a maximum after 1 d, exceeding the control values by sevenfold. Eight days after injury, c-MET levels, although decreasing, were still elevated above control values. An increase in the levels of activated c-MET, i.e., tyrosine-phosphorylated c-MET, was also evident as early as 12 h after injury. Histologic analyses demonstrated that the increase in c-MET immunoreactivity was most marked in the most severely damaged nephron segments in the outer medulla. In injured proximal tubules, the receptor was redistributed from an apical location to an intracellular location. DNA synthesis was increased in the injured kidneys, especially in the outer medulla, where the increase in c-MET protein levels was most prominent. The increase in DNA synthesis was first detected 12 h after the initial increase in activated c-MET levels. It is concluded that the early increases in the levels of c-MET protein and activated receptor support the hypothesis that HGF participates in the initiation of renal regeneration. In addition, the persistent elevation of c-Met protein levels suggests that prolonged and even late treatment with HGF may be of therapeutic value

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181801     DOI: 10.1681/ASN.V123531

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  19 in total

1.  In vitro and in vivo potentiating the cytotoxic effect of radiation on human U251 gliomas by the c-Met antisense oligodeoxynucleotides.

Authors:  Sheng-hua Chu; Zhi-an Zhu; Xian-hou Yuan; Zhi-qiang Li; Pu-cha Jiang
Journal:  J Neurooncol       Date:  2006-04-29       Impact factor: 4.130

Review 2.  MET overexpression and gene amplification in NSCLC: a clinical perspective.

Authors:  Lorenza Landi; Gabriele Minuti; Armida D'Incecco; Jessica Salvini; Federico Cappuzzo
Journal:  Lung Cancer (Auckl)       Date:  2013-06-18

Review 3.  In search of mechanisms associated with mesenchymal stem cell-based therapies for acute kidney injury.

Authors:  Danilo C de Almeida; Cassiano Donizetti-Oliveira; Priscilla Barbosa-Costa; Clarice St Origassa; Niels Os Câmara
Journal:  Clin Biochem Rev       Date:  2013-11

4.  Prevention of neutrophil extravasation by hepatocyte growth factor leads to attenuations of tubular apoptosis and renal dysfunction in mouse ischemic kidneys.

Authors:  Shinya Mizuno; Toshikazu Nakamura
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

5.  Cell confluence regulates hepatocyte growth factor-stimulated cell morphogenesis in a beta-catenin-dependent manner.

Authors:  Shuta Ishibe; J Erika Haydu; Akashi Togawa; Arnaud Marlier; Lloyd G Cantley
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

6.  Dephosphorylated Ser985 of c-Met is associated with acquired resistance to rechallenge injury in rats that had recovered from uranyl acetate-induced subclinical renal damage.

Authors:  Tomoyuki Fujikura; Akashi Togawa; Yuan Sun; Takamasa Iwakura; Hideo Yasuda; Yoshihide Fujigaki
Journal:  Clin Exp Nephrol       Date:  2012-12-19       Impact factor: 2.801

7.  Syndecan-1 Shedding Inhibition to Protect Against Ischemic Acute Kidney Injury Through HGF Target Signaling Pathway.

Authors:  Zhihui Lu; Nana Song; Bo Shen; XiaLian Xu; Yi Fang; Yiqin Shi; Yichun Ning; Jiachang Hu; Yan Dai; Xiaoqiang Ding; Jianzhou Zou; Jie Teng
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

8.  Met provides essential signals for liver regeneration.

Authors:  Malgorzata Borowiak; Alistair N Garratt; Torsten Wüstefeld; Michael Strehle; Christian Trautwein; Carmen Birchmeier
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

9.  Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction.

Authors:  Junwei Yang; Chunsun Dai; Youhua Liu
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

10.  Late intervention with the small molecule BB3 mitigates postischemic kidney injury.

Authors:  Prakash Narayan; Bin Duan; Kai Jiang; Jingsong Li; Latha Paka; Michael A Yamin; Scott L Friedman; Matthew R Weir; Itzhak D Goldberg
Journal:  Am J Physiol Renal Physiol       Date:  2016-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.